Uncategorised - European Medical Journal

Isabel O'Brien and Jade Williams

What should marketing and medical affairs invest in for Q4?

Join Jade and Isabel as they explore the critical trends that have shaped the industry in 2024 and what teams should leverage in Q4.

High Rates of Antibiotic-Resistant Bacteria Found in HIV Patients

A high prevalence of antibiotic-resistant bacteria has been detected in HIV patients at Jimma Medical Center, Ethiopia.

Enhancing Pelvic Floor Muscle Training with Biofeedback for Urinary Incontinence

A randomised clinical trial found that pressure-mediated biofeedback used as an adjunct to supervised pelvic floor muscle training improves postpartum stress urinary incontinence.

Rejuvenating Ageing Hands: Platelet Extract and Vitamin C Compared

Treatments such as antioxidants, chemical peels, and laser therapy are available, but recent attention has turned to human platelet extract and vitamin C serums.

Emergency Department Costs: $207M and 2,143 Young Lives

A national study recently highlighted the potential life-saving impact of enhancing emergency departments’ (ED) pediatric readiness across the United States.

Annual DXA Screening “Essential” After Lung Transplant

A newly published study recommends annual DXA screenings for patients in the first 2 years after lung transplants to monitor bone mineral density (BMD) changes.

Rwanda Nears End of Marburg Outbreak

Rwanda has begun the 42-day countdown to officially declare an end to the Marburg virus outbreak, having discharged its last patient on November 8, 2024.

How Does Asthma Alter Children’s Memory Development?

Children with asthma, particularly those with an early onset, may experience slower memory development and face challenges in cognitive functions.

New Algorithm Enhances Precision in Long COVID Cohorts

Researchers have developed a precision phenotyping algorithm that significantly advances the identification of long COVID, or post-acute sequelae of COVID-19 (PASC), in patient records.

Red arrow tracking bar chart that is ascending in height

BMS, Gilead and Sanofi lead Q3 2024 market cap growth

The third quarter of 2024 brought a mix of gains and modest declines for the pharmaceutical industry’s top players, according to GlobalData.